On the upside
Angiotech Pharmaceuticals' (Nasdaq: ANPI) Zilver PTX Stent received CE Mark approval and will be launched in Europe.
Second quarter earnings for Farmer Mac (NYSE: AGM) rose.
Thomas Weisel Partners upgraded Brigham Exploration (Nasdaq: BEXP) saying that the company's petroleum inventory may be much larger than expected.
On the downside
Captstone Turbine (Nasdaq: CPST) blamed higher expenses for widening first quarter losses to fall short of expectations.
Anthracite Capital (NYSE: AHR) swung to a loss for the second quarter and warned that it may not meet some principal paydown requirements.
PAREXEL International (Nasdaq: PRXL) disappointed with lower fourth quarter earnings as revenue fell.
In the broad market, declining issues outpaced advancers by a margin of more than 7 to 2 on the NYSE and nearly the same on Nasdaq. The Russell 2000 which tracks small cap stocks fell 11 points to 560.
